Skip to content

The Immune Response to Stroke

The Immune Response to Stroke

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05277129
Enrollment
40
Registered
2022-03-14
Start date
2021-06-24
Completion date
2029-06-06
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia, Stroke, Acute

Brief summary

Some patients develop cognitive decline after a stroke, but we don't always understand the mechanisms. It has been proposed that a proportion of the patients develop an autoimmune immune response, and that this could potentially explain the cognitive decline in some of the patients. The current study aims to investigate this hypothesis in a subgroup of patients with stroke.

Interventions

OTHERAnalysis of post-stroke immune responses

Analysis of immune responses in peripheral blood

Sponsors

University of Oslo
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Stroke \< 72 h * Age \> 18 years

Exclusion criteria

* Brain hemorrhage verified by CT or MRI scan * Previous or present immunological disease or other serious comorbidity * Ongoing immune respons after infection or vaccination \< 1 month * Cognitive without ability to understand and/or give an informed consent to participate in the study

Design outcomes

Primary

MeasureTime frame
The B cell and T cell response in peripheral blood1 day (subject inclusion)

Countries

Norway

Contacts

Primary ContactAndreas Lossius, MD, PhD
postmottak@medisin.uio.no+47 930 68 515

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026